Early intervention with azelastine nasal spray may reduce viral load in SARS-CoV-2 infected patients
JP Klussmann, M Grosheva, P Meiser, C Lehmann… - Scientific Reports, 2023 - nature.com
With the changing epidemiology of COVID-19 and its impact on our daily lives, there is still
an unmet need of COVID-19 therapies treating early infections to prevent progression. The …
an unmet need of COVID-19 therapies treating early infections to prevent progression. The …
Phase II trial of the impact 0.5% povidone‐iodine nasal spray (Nasodine®) on shedding of SARS‐CoV‐2
PL Friedland, S Tucker - The Laryngoscope, 2024 - Wiley Online Library
Objective A Phase II trial was conducted to determine if nasal disinfection with a commercial
Good Manufacturing Practice‐manufactured 0.5% povidone‐iodine nasal spray …
Good Manufacturing Practice‐manufactured 0.5% povidone‐iodine nasal spray …
Phase 1 study of the iodine absorption, safety, and tolerability of a 0.5% povidone-iodine nasal spray (Nasodine)
PL Friedland, TM Polasek… - International forum of …, 2024 - pubmed.ncbi.nlm.nih.gov
Phase 1 study of the iodine absorption, safety, and tolerability of a 0.5% povidone-iodine nasal
spray (Nasodine) Phase 1 study of the iodine absorption, safety, and tolerability of a 0.5 …
spray (Nasodine) Phase 1 study of the iodine absorption, safety, and tolerability of a 0.5 …
[PDF][PDF] Nasal Rinsing Efficacious Curing Covid-19, Low Temperature May Be Crucial Of Priming Intranasal Administration for Viral Sterilization
Y Tan - 2024 - researchgate.net
Background The global pandemic of Coronavirus Disease 2019 (covid-19) is ongoing and,
SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) is the causative …
SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) is the causative …
[引用][C] Side effects of antiseptic drugs and disinfectants with experience of the third year of COVID-19
DW Lachenmeier - 2023 - Elsevier